Identification of etamiphylline and metabolites in equine plasma and urine by accurate mass and liquid chromatography/tandem mass spectrometry.

The research article is about an analysis of the drug etamiphylline and its metabolites in horse blood and urine using liquid chromatography and mass spectrometry.

Objective of the Study

• The study aimed to identify the presence of etamiphylline camsylate (Millophylline V), a drug used in veterinary medicine, and its metabolites in horse plasma and urine. The drug was administered intravenously to two horses, and the samples were collected up to 32 hours post-administration.

Methodology

• The researchers used a solid phase extraction (SPE) method to extract the unhydrolyzed plasma and urine of horses.
• They employed a linear ion trap mass spectrometer and accurate mass analysis on an orbitrap mass spectrometer to confirm the identity of etamiphylline and its metabolites.

Results of the Study

• The main metabolite that was observed in horse’s urine and plasma samples is desethyletamiphylline which results from the N-deethylation of etamiphylline.
• A metabolite from the demethylation of etamiphylline was also detected in both urine and plasma samples.
• The third minor metabolite was hypothesized to have resulted from a simultaneous N-deethylation and demethylation of the parent drug, etamiphylline.

Implications of the Study

• The identification of metabolites is important for understanding the metabolic pathway and potential pharmacological activity of the parent drug.
• The data obtained may contribute to the body of knowledge regarding the pharmacokinetics and metabolism of etamiphylline in horses. This could assist in optimizing its therapeutic efficacy and safety, and could also be helpful in detecting its misuse in horse racing.